New Spinal Cord Drug in Brazil Offers Hope for Paralysis Recovery.mp4

A breakthrough drug made from placental proteins is now entering human clinical trials.

Developed by researchers at the Federal University of Rio de Janeiro (UFRJ) in partnership with the Cristália laboratory, Polylaminin represents a promising advance in regenerative medicine. The drug is injected directly into the site of spinal cord injury and is designed to actively stimulate the growth of new axons and help rebuild neural connections, rather than simply stabilizing damage.

As of early 2026, Brazil’s health regulatory agency Anvisa has approved the first phase of human trials to evaluate safety in patients with complete spinal cord injuries. Early observations suggest that some individuals with paraplegia and quadriplegia experienced improvements in motor function and sensory perception.

While these findings are encouraging, further rigorous studies and larger clinical trials are required before the treatment can be widely used.

#regenerativemedicine #neuroscience #spinalcord #innovation #healthscience #fblifestyle

Видео New Spinal Cord Drug in Brazil Offers Hope for Paralysis Recovery.mp4 канала Medicine Today